NO20005293L - Visse tiolininhibitorer av endotelinomdannende enzym - Google Patents

Visse tiolininhibitorer av endotelinomdannende enzym

Info

Publication number
NO20005293L
NO20005293L NO20005293A NO20005293A NO20005293L NO 20005293 L NO20005293 L NO 20005293L NO 20005293 A NO20005293 A NO 20005293A NO 20005293 A NO20005293 A NO 20005293A NO 20005293 L NO20005293 L NO 20005293L
Authority
NO
Norway
Prior art keywords
thiolin
inhibitors
certain
converting enzyme
endothelin converting
Prior art date
Application number
NO20005293A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005293D0 (no
Inventor
Stephane De Lombaert
Cynthia Anne Fink
Fariborz Firoozina
Denton Wade Hoyer
Acro Yingcheu Jeng
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20005293D0 publication Critical patent/NO20005293D0/no
Publication of NO20005293L publication Critical patent/NO20005293L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20005293A 1998-04-23 2000-10-20 Visse tiolininhibitorer av endotelinomdannende enzym NO20005293L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6526598A 1998-04-23 1998-04-23
PCT/EP1999/002690 WO1999055726A1 (en) 1998-04-23 1999-04-21 Certain thiol inhibitors of endothelin-converting enzyme

Publications (2)

Publication Number Publication Date
NO20005293D0 NO20005293D0 (no) 2000-10-20
NO20005293L true NO20005293L (no) 2000-12-18

Family

ID=22061502

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005293A NO20005293L (no) 1998-04-23 2000-10-20 Visse tiolininhibitorer av endotelinomdannende enzym

Country Status (16)

Country Link
EP (1) EP1073674A1 (id)
JP (1) JP4350306B2 (id)
KR (1) KR20010034816A (id)
CN (1) CN1297453A (id)
AU (1) AU3819999A (id)
BR (1) BR9909805A (id)
CA (1) CA2323691A1 (id)
HU (1) HUP0101640A3 (id)
ID (1) ID26822A (id)
IL (1) IL138246A0 (id)
NO (1) NO20005293L (id)
PL (1) PL343594A1 (id)
RU (1) RU2000129510A (id)
SK (1) SK15812000A3 (id)
WO (1) WO1999055726A1 (id)
ZA (1) ZA200004680B (id)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6423727B1 (en) 1998-04-23 2002-07-23 Novartis Ag Certain thiol inhibitors of endothelin-converting enzyme
US6426354B1 (en) 1998-04-23 2002-07-30 Novartis Ag Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
AU2001254776A1 (en) * 2000-04-06 2001-10-23 Novartis Ag Organic compounds
US6777443B2 (en) 2001-05-15 2004-08-17 Novartis Ag Dipeptide derivatives
JP4263095B2 (ja) * 2001-09-21 2009-05-13 ノバルティス アクチエンゲゼルシャフト Aceおよびnepの両阻害剤としてのピラン誘導体
TWI259079B (en) 2002-02-08 2006-08-01 Merck & Co Inc N-biphenyl(substituted methyl)aminocycloalkanecarboxamide derivatives
US7091380B2 (en) 2002-02-08 2006-08-15 Merck & Co., Inc. N-biphenylmethyl aminocycloalkanecarboxamide derivatives
WO2003074478A1 (en) * 2002-03-05 2003-09-12 Sumitomo Chemical Company, Limited Process for the preparation of biaryl compounds
AU2003303217A1 (en) * 2002-12-20 2004-07-14 Bayer Healthcare Ag Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
US7452875B2 (en) 2003-09-26 2008-11-18 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7427611B2 (en) 2003-09-26 2008-09-23 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7262184B2 (en) 2003-09-26 2007-08-28 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
PT1706121E (pt) * 2004-01-12 2008-12-04 Solvay Pharm Bv Inibidores de endopeptidase neutra (nep) e endopeptidase humana solúvel (hsep) para profilaxia e tratamento de distúrbios neurodegenerativos
JP4047365B2 (ja) 2006-01-11 2008-02-13 生化学工業株式会社 シクロアルカンカルボキサミド誘導体及びその製造方法
WO2007080884A1 (ja) * 2006-01-11 2007-07-19 Seikagaku Corporation シクロアルキルカルボニルアミノ酸エステル誘導体及びその製造方法
JP3975226B2 (ja) 2006-01-11 2007-09-12 生化学工業株式会社 シクロアルキルカルボニルアミノ酸誘導体及びその製造方法
JP2011517313A (ja) 2007-12-11 2011-06-02 ビアメト ファーマシューティカルズ,インク. 金属結合部分を標的化部分と組み合わせて使用する金属酵素阻害剤
CN104725279B (zh) * 2015-02-12 2018-03-02 威海迪素制药有限公司 一种N‑Boc‑联苯丙氨酸衍生物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780498A (en) * 1993-11-01 1998-07-14 Ciba-Geigy Japan Limited Endothelin receptor antagonists
ATE193706T1 (de) * 1993-11-16 2000-06-15 Novartis Ag Zyklische aminosäure-derivate mit ace und nep inhibierender aktivität
FR2745571B1 (fr) * 1996-03-04 1998-06-19 Inst Nat Sante Rech Med Nouveaux derives soufres comportant une liaison amide, leur procede de preparation, leur application a titre de medicaments, et les compositions pharmaceutiques les renfermant

Also Published As

Publication number Publication date
ZA200004680B (en) 2001-04-25
HUP0101640A3 (en) 2002-10-28
EP1073674A1 (en) 2001-02-07
IL138246A0 (en) 2001-10-31
NO20005293D0 (no) 2000-10-20
ID26822A (id) 2001-02-15
SK15812000A3 (sk) 2001-03-12
JP2002513032A (ja) 2002-05-08
JP4350306B2 (ja) 2009-10-21
CN1297453A (zh) 2001-05-30
HUP0101640A2 (hu) 2001-09-28
RU2000129510A (ru) 2002-11-10
BR9909805A (pt) 2000-12-26
AU3819999A (en) 1999-11-16
KR20010034816A (ko) 2001-04-25
CA2323691A1 (en) 1999-11-04
PL343594A1 (en) 2001-08-27
WO1999055726A1 (en) 1999-11-04

Similar Documents

Publication Publication Date Title
NO20005293L (no) Visse tiolininhibitorer av endotelinomdannende enzym
NO20014535L (no) Inhibitorer av IMPDH-enzym
NO20004219D0 (no) Inhibitorer av fosfolipaseenzymer
NO20004220L (no) Inhibitorer av fosfolipaseenzymer
NO965365D0 (no) Hemmere av interleukin-1 omdannende enzym
EP1127054A4 (en) INHIBITORS OF IMPDH ENZYME
NO20004550D0 (no) Enzyminhibitorer
DK1066374T3 (da) Amylolytiske enzymvarianter
LV11986A (lv) Rotamazes fermenta aktivitates inhibitori
EE9800125A (et) Rotamaasse ensümaatilise aktiivsuse inhibiitorid
NO993717D0 (no) Anvendelse av gastrointestinale lipase-inhibitorer
NO20016034L (no) Inhibitorer av aspartylprotease
NO20005537D0 (no) Suksinamidinhibitorer av interleukin-1<beta> omdannende enzym
DE60038350D1 (de) Angiotensin-Converting-Enzyme-Hemmer
DE60024101D1 (de) Enzyminhibitoren
EP1379633A4 (en) ENZYMATIC CHANGE OF SEEDS VAN PLANTAGO PSYLLIUM
TR199800847A3 (tr) Bir anjiyotensin dönüstürücü enzim inhibitörünün sabit doz bilesimi.
DE60033943D1 (de) Schwefelfreie enzyme
DE69427508D1 (de) Endothelin konvertierendes Enzym bestehend aus Apolipoprotein B
DK0944645T3 (da) Inhibitorer af interleukin-1beta-konverterende enzym
DK1224254T3 (da) Enzymatisk gråningsinhibitor
DK1080104T3 (da) Bestemte heteroaryl-substituerede thiolinhibitorer af endothelinomdannende enzym
ID16708A (id) Inhibitor aktivitas enzim rotamase
FI20001808A0 (fi) Uusi entsyymi
SE9603101D0 (sv) Medicinsk användning av enzym

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application